One of the world's largest Tier-1 military drone manufacturers placed a follow-on order for an additional Mobilicom Mesh networking productThe repeat orders demonstrate market traction for Mobilicom's solutions that are
Gainers
Tempest Therapeutics, Inc. (NASDAQ: TPST) shares jumped 1067% to $2.80 after the company released new data demonstrating superiority of TPST-1120 arm across multiple study endpoints in first-line hepatocellular carcinoma study.